Data on Singaporeans Assessed to Have Allergic Reactions to First Dose of mRNA COVID-19 Vaccine
Ministry of HealthSpeakers
Summary
This question concerns the management of Singaporeans who experienced allergic reactions to the first dose of mRNA COVID-19 vaccines and their access to alternative vaccinations. Dr Tan Wu Meng asked for data on these individuals, their interest in the Sinovac vaccine, and whether the Ministry would subsidize allergy specialist referrals. Minister for Health Ong Ye Kung stated that about 7,100 individuals were affected, with 3,900 opting for Sinovac vaccinations at four public hospitals for closer monitoring. Minister for Health Ong Ye Kung noted that wait times are between two and four weeks and that the Ministry is currently working to increase capacity. Finally, Minister for Health Ong Ye Kung clarified that while second mRNA doses are discouraged, individuals may seek reassessment through a medical memo at their own cost.
Transcript
29 Dr Tan Wu Meng asked the Minister for Health (a) to date, how many Singaporeans are assessed to have allergic reactions to the first dose of a mRNA COVID-19 vaccine; (b) whether there is data on the current number of these Singaporeans who have registered for the Sinovac vaccine and the average waiting time before receiving the first dose; and (c) whether the Ministry can facilitate a subsidised referral to an allergy specialist for these Singaporeans seeking a reassessment of their allergy status in order to receive the second dose of a mRNA vaccine.
Mr Ong Ye Kung: About 7,100 individuals were assessed to have allergic reactions to the first dose of an mRNA COVID-19 vaccine, and have been invited to complete their vaccination with two more doses of the Sinovac-CoronaVac vaccine.
Three thousand nine hundred individuals have indicated interest and will receive the vaccination at four public hospital clinics for closer monitoring given their reaction to the mRNA vaccine. The wait time between registering with the public hospital clinics for vaccination and receiving a first dose of vaccine is between two and four weeks. MOH is increasing capacity so that individuals can receive their vaccinations sooner.
Individuals who have allergic reactions from their first dose of mRNA vaccine are advised not to take the second dose of the mRNA vaccine. However, if they wish to seek a reassessment of their suitability for the second dose of mRNA vaccine, they may provide a supporting memo from any medical provider at their own cost. If the attending doctor at the vaccination provider agrees with the assessment, the individual may proceed with the second dose of mRNA vaccine.